Syphilis dark field microscopy: Difference between revisions
Jump to navigation
Jump to search
(Created page with "==Dark field microscopy== *Dark field microscopy may be performed in cases wherein serologic tests do not correspond with [[syphilis physical examination|clinical findings...") |
m (Changes made per Mahshid's request) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
*[[Dark field microscopy]] may be performed in cases wherein serologic tests do not correspond with [[syphilis physical examination|clinical findings]] suggestive of early syphilis. | *[[Dark field microscopy]] may be performed in cases wherein serologic tests do not correspond with [[syphilis physical examination|clinical findings]] suggestive of early syphilis. | ||
| Line 23: | Line 22: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
Latest revision as of 18:54, 18 September 2017
- Dark field microscopy may be performed in cases wherein serologic tests do not correspond with clinical findings suggestive of early syphilis.
- It may also be helpful in the evaluation of cutaneous lesions such as chancre or condylomata lata.
- Direct fluorescent antibody (DFA-TP) assay of fixed smears may be indicated if dark field microscopy is not available.
- Dark field microscopy and DFA-TP assay have a specificity rate of 85-92%
Resources
References
- ↑ Workowski KA, Berman S (2010). "Sexually transmitted diseases treatment guidelines, 2010". MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports / Centers for Disease Control. 59 (RR-12): 1–110. PMID 21160459. Retrieved 2012-02-16. Unknown parameter
|month=ignored (help)